Does anybody remember the reason the FDA told us that they did not want us to set up another trial for mild/moderate. It really pisses me off that almost 1 year later, monoclonal antibodies are showing promise preventing covid patients moving to severe. We were one of the first to run a trial and are results were strong even though we didn’t hit our primary endpoints. Once again, we were shut down by the FDA after showing promise and with a little guidance, we could of been saving patients months ago. Hard not be believe we are being slow played at the least!?!